Quantitative Appraisal of Ventricular Cerebrospinal Fluid Biomarkers in Neuropathologically Diagnosed Parkinson’s Disease Cases Lacking Alzheimer’s Disease Pathology

Identifying biomarkers that distinguish Parkinson’s disease (PD) from normal control (NC) individuals has the potential to increase diagnostic sensitivity for the detection of early-stage PD. A previous proteomic study identified potential biomarkers in postmortem ventricular cerebrospinal fluid (V-...

Descripción completa

Detalles Bibliográficos
Autores principales: Maarouf, Chera L., Beach, Thomas G., Adler, Charles H., Malek-Ahmadi, Michael, Kokjohn, Tyler A., Dugger, Brittany N., Walker, Douglas G., Shill, Holly A., Jacobson, Sandra A., Sabbagh, Marwan N., Roher, Alex E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603385/
https://www.ncbi.nlm.nih.gov/pubmed/23533154
http://dx.doi.org/10.4137/BMI.S11422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603385/
https://www.ncbi.nlm.nih.gov/pubmed/23533154
http://dx.doi.org/10.4137/BMI.S11422

Ejemplares similares